YESCARTA Trademark

Trademark Overview

On Monday, June 10, 2019, a trademark application was filed for YESCARTA with the United States Patent and Trademark Office. The USPTO has given the YESCARTA trademark a serial number of 88466399. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Kite Pharma, Inc.. The YESCARTA trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
yescarta

General Information

Serial Number88466399
Word MarkYESCARTA
Filing DateMonday, June 10, 2019
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6254120
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements

Goods and ServicesCustom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
Translation of Words in MarkThe wording "YESCARTA" has no meaning in a foreign language.

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSaturday, June 22, 2019
Primary Code040
First Use Anywhere DateTuesday, October 31, 2017
First Use In Commerce DateTuesday, October 31, 2017

Trademark Owner History

Party NameKite Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404
Party NameKite Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404
Party NameKite Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 1, 2020EXPARTE APPEAL TERMINATED
Thursday, October 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 9, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 9, 2020EX PARTE APPEAL-INSTITUTED
Wednesday, September 9, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, September 9, 2020EXPARTE APPEAL RECEIVED AT TTAB
Thursday, March 12, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 12, 2020FINAL REFUSAL E-MAILED
Thursday, March 12, 2020FINAL REFUSAL WRITTEN
Wednesday, March 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020ASSIGNED TO LIE
Wednesday, February 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 3, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, September 3, 2019PRIORITY ACTION E-MAILED
Tuesday, September 3, 2019PRIORITY ACTION WRITTEN
Friday, August 30, 2019ASSIGNED TO EXAMINER
Saturday, June 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 13, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

yescarta custom manufacturing preparations immunotherapy pharmaceutical blood biological tissue cells